Faculty of Biological Sciences

Research Bulletin

Molecule fights cancer on two fronts

14th November 2014

Researchers at the University of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms in the spread of malignant tumours through the body.

Molecule fights cancer on two frontstitle=

A study published in the journal PLOS ONE today reports that the synthetic molecule JK-31 blocks the signalling of a “growth factor” chemical that promotes the creation of networks of blood vessels to feed tumours. But the researchers also found that the new molecule intervened directly in the growth of the cancer itself, inhibiting a protein that controls the division and proliferation of malignant cells.

Dr Vas Ponnambalam, Reader in Human Disease Biology in the University of Leeds’ Faculty of Biological Sciences, said: “The ability to mount this two-pronged attack on cancerous growths is exciting. There is a great need for better drugs against cancer than what we currently have and JK31 may represent an important addition to the toolkit for drug makers developing the next generation of drugs.”

The researchers observed the effect of the synthetically produced molecule, JK-31, on the growth and proliferation of a model human breast cancer cell line and found that it effectively blocked the protein cyclin-dependent kinase 1 (CDK1), which plays a key part in the process of the division of cancer cells, and therefore inhibited the proliferation of the cells.

In a separate laboratory experiment, they found the same JK-31 molecule also blocked a specific growth factor (VEGF-A) produced by the cancer to attract the growth of blood vessels. Other molecules exhibiting similar dual effects are known but JK-31 is the only compound so far shown to successfully target CDK1 and block VEGF-A.
The research was funded by the BBSRC, Pfizer Global Inc., the Medical Research Council and the British Heart Foundation.

Further information

Dr Ponnambalam is available for interview.

Contact: Chris Bunting, Senior Press Officer, University of Leeds; phone: +44 113 343 2049 or email c.j.bunting@leeds.ac.uk.

The full paper: Antony M. Latham, Jayakanth Kankanala, Gareth W Fearnley, Matthew C Gage, Mark T Kearney, Shervanthi Homer-Vanniasinkam, Stephen B Wheatcroft, Colin W G Fishwick, and Sreenivasan Ponnambalam, “ In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis,” PLoS One (2014) is available on request from the University of Leeds press office to members of the media.

Related links

Medical News - University of Leeds researchers make new synthetic anti-cancer molecule

MNT - Molecule fights cancer on 2 fronts


Recent Grants

Alan Berry, Wellcome Trust (Oct 2014), £749,865

Paul Knox, EU (Oct 2014), £167,229

Andrew Peel, BBSRC (Sep 2014), £371,598

Lars Jeuken, BBSRC (Sep 2014), £313,463

Neil Ranson, BBSRC (Aug 2014), £355,253

Stuart Egginton, BHF (Aug 2014), £271,094

Darren Tomlinson, Mike McPherson, Technology Strategy Board (Aug 2014), £98,665

Peter Henderson, Leverhulme Trust (Aug 2014), £15,222

Mike McPherson (and colleagues in the School of Chemistry), EPSRC (Jul 2014), £819,880

Peter Stockley, Neil Ranson, BBSRC (Jul 2014), £455,787

Sheena Radford, Univesity of Michigan (Jul 2014), £138,452

Ryan Seipke, British Society Antimicrobial Chemistry (Jun 2014), £11,960

John Trinick, BHF (Jun 2014), £222,614

Chris West, Leverhulme Trust (Jun 2014), £181,241

Jon Lippiat, Darren Tomlinson, BBSRC (May 2014), £125,174

Christine Foyer, Royal Society (May 2014), £24,000

David Brockwell, Sheena Radford, Medimmune Ltd (Apr 2014), £337,661

Peter Stockley, Wellcome Trust (Apr 2014), £251,019

Mike McPherson, Wellcome Trust (Apr 2014), £146,596

Andrew Macdonald, Kidney Research Fund UK (Apr 2014), £127,237

Elwyn Isaac, DEFRA (Apr 2014), £126,512

Mike McPherson (and colleagues in School of Design), Technology Strategy Board (Apr 2014), £114,350

Paul Millner, Peter Stockley, Darren Tomlinson, YCR (Apr 2014), £95,874

Carrie Ferguson, Karen Birch, Shaunna Burke, Heart Research UK (Apr 2014), £60,140

Tim Benton, Technology Strategy Board (Apr 2014), £24,969

Bill Kunin, Technology Strategy Board (Apr 2014), £21,244

Dave Westhead, MRC (Apr 2014), £18,304

Brendan Davies, BBSRC (Mar 2014), £451,829

Jim Deuchars, MRC (Mar 2014), £300,000

Urwin, Howard Atkinson, British Potato Council (Mar 2014), £69,953

Adam Kupinski, Children with Cancer (Mar 2014), £50,000

Anastasia Zhuravleva, Royal Society (Mar 2014), £14,973

Urwin, Howard Atkinson, Agriculture & Horticulture Develpmnt Brd (Mar 2014), £13,990

Alison Baker, Steve Baldwin, BBSRC (Feb 2014), £403,439

Sarah Zylinski, BBSRC (Feb 2014), £355,869

Dave Lewis, Nigel Hooper, Tony Turner, Hugh Pearson, James Duce, Alzheimer's Society (Feb 2014), £29,871

Ronaldo Ichyama, Samit Chakrabarty, International Spinal Research Trust (Jan 2014), £304,600

Brendan Davies, BBSRC/Bayer Crop Science SA-NV (Jan 2014), £470,053

Adrian Goldman, Steve Baldwin, Stephen Muench, Thomas Edwards, Arwen Pearson , BBSRC (Jan 2014), £467,103

Stefan Kepinski, BBSRC (Jan 2014), £359,269

Elwyn Isaac, EU (Jan 2014), £179,445

Dave Westhead, Leukaemia & Lymphoma Research (Jan 2014), £105,937

Eileen Ingham, Joanne Tipper, Depuy International Ltd (Jan 2014), £48,121

John Barr, Thomas Edwards, MRC (Dec 2013), £469,505

Alex O'Neill, MRC (Dec 2013), £349,017

Tim Benton, NERC (Dec 2013), £31,422

Recent News

FBS team shows how statins can directly affect the cardiac muscle cell

16th October 2014

New article published in PLOS ONE by Dr Sarah Calaghan and co-workers.

more

£11 million funding for doctoral training partnership

3rd October 2014

The universities of Leeds, York and Sheffield have been chosen to help spearhead the training of the next generation of biological scientists

more

Professor Sheena Radford Lecture

2nd October 2014

Sir Alan Langlands is hosting a special event in honour of Professor Sheena Radford's election as a Fellow of the Royal Society.

more

The University of Leeds is investing in 250 new academic fellowships.

30th September 2014

Are you one of the 250 Great Minds we are looking for?

more

FBS Professor discovers a novel role for platelets

29th September 2014

New article published in PLOS ONE Journal by Prof Stuart Egginton - Platelets and angiogenesis: a differential effect

more

Pharmacology prize for UG student

23rd September 2014

Congratulations to Katie Musialowski, BSc Pharmacology (International), who has been awarded the BSc Pharmacology Prize 2014 by the British Pharmacological Society.

more

Guest lecture from Leeds Biochemistry alumnus, Dr Nicholas Lydon

2nd September 2014

Leeds University alumnus Dr Nicholas Lydon, FRS, will visit the University on Monday 29 September to deliver a guest lecture.

more

Healthy Brains at Leeds: Demystifying Dementia event

29th August 2014

Healthy Brains at Leeds: Demystifying Dementia event

more

Impact Stories

Research by Dr Simon Goodman shows how large the effect of human activity has been on the Caspian Seal.
more

Dr Simon Goodman has investigated the disease risks to the native Galapagos fauna.
more

Professor Ingham examinines the biological effects of wear particles from joint replacements.
more

Research carried out by Dr Ichiyama has led to the development of a rehabilitation training regime which allows an animal with spinal cord injury causing complete paralysis to walk again.
more

All impact stories